Welcome guest, Sign in

Home

X
加载中

Prion diseases are transmissible, fatal, neurodegenerative diseases in human and animals. The molecular basis of neurodegeneration in prion diseases is largely unclear. Developing a cellular model capable of monitoring prion-induced cytotoxicity would be a promising approach for better understanding the prion pathogenesis. One candidate cellular assay is a model based on neurospheres, which contains neural stem cells (NSCs). Both undifferentiated and differentiated NSCs have been demonstrated to be permissive to prion infection, and prion-induced cytopathic changes in differentiated neruosphere cultures were reported (Iwamaru et al., 2013). This protocol describes the procedure to induce differentiation of NSCs from transgenic mice overexpressing prion protein (tga20 mice) into cultures susceptible for prion infection.

Thanks for your further question/comment. It has been sent to the author(s) of this protocol. You will receive a notification once your question/comment is addressed again by the author(s).
Meanwhile, it would be great if you could help us to spread the word about Bio-protocol.

X

Neural Stem Cell Differentiation and Prion Infection

Neuroscience > Development > Neuron
Authors: Yoshifumi Iwamaru
Yoshifumi IwamaruAffiliation: Influenza and Prion Disease Research Center, National Institute of Animal Health (NIAH), Tsukuba, Japan
Bio-protocol author page: a1216
Takato Takenouchi
Takato TakenouchiAffiliation: Division of Animal Sciences, National Institute of Agrobiological Sciences, Tsukuba, Japan
Bio-protocol author page: a1217
 and Hiroshi Kitani
Hiroshi KitaniAffiliation: Division of Animal Sciences, National Institute of Agrobiological Sciences, Tsukuba, Japan
For correspondence: kitani@affrc.go.jp
Bio-protocol author page: a1218
Vol 4, Iss 6, 3/20/2014, 3366 views, 0 Q&A, How to cite
DOI: http://dx.doi.org/10.21769/BioProtoc.1082

[Abstract] Prion diseases are transmissible, fatal, neurodegenerative diseases in human and animals. The molecular basis of neurodegeneration in prion diseases is largely unclear. Developing a cellular model capable of monitoring prion-induced cytotoxicity would be a promising approach for better understanding the prion pathogenesis. One candidate cellular assay is a model based on neurospheres, which contains neural stem cells (NSCs). Both undifferentiated and differentiated NSCs have been demonstrated to be permissive to prion infection, and prion-induced cytopathic changes in differentiated neruosphere cultures were reported (Iwamaru et al., 2013). This protocol describes the procedure to induce differentiation of NSCs from transgenic mice overexpressing prion protein (tga20 mice) into cultures susceptible for prion infection.

Keywords: Neural stem cell, Differentiation culture, Prion infection, Cellular pathogenesis

Materials and Reagents

  1. Mouse-adapted prion infected mice brains (terminally ill CD-1 female mice intracerebrally inoculated with mouse adapted scrapie, at ca. 6 months of age)
  2. Ethanol (99.5% EtOH) (Nacalai Tesque, catalog number: 14713-95)
  3. Dulbecco's phosphate buffered saline without Ca and Mg (D-PBS) (Nacalai Tesque, catalog number: 14249-95)
  4. Hank's balanced salt solution (HBSS) (Sigma-Aldrich, catalog number: H8264)
  5. Dulbecco's modified Eagle's medium/nutrient F-12 Ham (DMEM/F12 Ham) (Sigma-Aldrich, catalog number: D8437)
  6. N-2 supplement (Life Technologies, catalog number: 17502-048)
  7. Bovine serum albumin solution (30% BSA in D-PBS) (Sigma-Aldrich, catalog number: A9576)
  8. Accutase (Innovative Cell Technologies, catalog number: AT-104)
  9. 99% Acetone (Nacalai Tesque, catalog number: 00310-95)
  10. Water for embryo transfer (sterile-filtered) (Sigma-Aldrich, catalog number: W1503)
  11. 35% hydrochlolic acid (HCl) ( Nacalai Tesque, catalog number: 18321-05)
  12. Penicillin-Streptomycin (Sigma-Aldrich, catalog number: P0781)
  13. Epidermal growth factor human (EGF) (Sigma-Aldrich, catalog number: E9644) (see Recipes)
  14. Fibroblast growth factor-basic human (bFGF) (Sigma-Aldrich, catalog number: F0291) (see Recipes)
  15. Neurosphere basal medium (see Recipes)
  16. Fibronectin (Sigma-Aldrich, catalog number: F4759) (see Recipes)
  17. Glass wash solution (see Recipes)
  18. Differentiation-inducing medium (see Recipes)

Equipment

  1. Falcon 15 ml conical centrifuge tubes (Corning, catalog number: 352096)
  2. Falcon 50 ml conical centrifuge tubes (Corning, catalog number: 352070)
  3. Corning primaria 6 well clear multiwell plate (Corning, catalog number: 353846)
  4. Nunc 60mm dish with HydroCell surface (Thermo Fisher Scientific, catalog number: 174912)
  5. Glass coverslips (22 x 22 mm) (Asahi Techno Glass Corporation, catalog number: 2918)
  6. ART 1000 REACH tips (Thermo Fisher Scientific, catalog number: 2079)
  7. Multi-beads shocker cell disruptor (Yasui Kikai Corporation)
  8. 2 ml screw-cap micro centrifuge tubes-freestanding (Sarstedt K.K., catalog number: 72.664.002)
  9. Zirconia ball (1 mm diameter) (As One YTZ1)
  10. Plastic square dishes (Eiken Chemical, model: AW2000)
  11. 1.5 ml screw-cap micro centrifuge tubes (Sarstedt K.K., catalog number: 72.687.028J)
  12. Sealed sonicator (Biorupter®, model: UCD250)
  13. Centrifuge (Kubota Corporation, model: 5220)
  14. CO2 incubator (set at 37 °C and 5% CO2-95% air)
  15. Reciprocal shaker (Taitec, model: NR-1)
  16. Bio-safety cabinet (ORIENTAL GIKEN, model: LAD-1300XB3)
  17. Deep freezer (set at -80 °C)
  18. Fine forceps (NAPOX A-5, 110 mm; NAPOX MA-45, 110 mm)
  19. C-Chip disposable hemocytometer (iN CYTO, DHC-N01 Neubauer Improved)
  20. Electric balance (Mettler Toledo, model: AB104-S)

Procedure

  1. Preparation of glass coverslips
    1. Immerse 24 glass coverslips in a plastic square dish containing glass wash solution (25 -30 ml) for 12-16 h at 25 °C with gentle rocking using a reciprocal shaker at 50 rpm (Figure 1).


      Figure 1. Washing process of glass coverslips in a plastic square dish on a reciprocal shaker

    2. Place the coverslips in 50 ml conical tube and wash the coverslips with 35 ml acetone for 1 min three times with inversion of the tube.
    3. In a bio-safety cabinet, after air-dry for 30 sec, pass an individual coverslip over a flame briefly and place one cover slip on the bottom of each well of 6 well plate.
    4. In a bio-safety cabinet, coat coverslips with 1.5 ml of fibronectin solution and incubate at 37 °C for 12-16 h. After aspiration of fibronectin solution, air-dry coverslips laid on the bottom of the well for 30 min (Figure 2).


      Figure 2. Air-drying of fibronectin-coated glass coverslips laid in 6 well plate in a bio-safety cabinet

  2. Preparation of prion-infected brain homogenate
    Prions, the infectious agents of fatal neurological diseases in humans and animals, are known to be highly resistant to conventional physical and chemical procedures for inactivating or eliminating microbes. To minimize the bio-hazard risk, before you handle prion-infected tissues, you have to contact with biosafety officers in your department and comply with the biosafety regulations. Required personal protection equipments, decontamination methods, waste management and procedures should be referred to each institutional bio-safety regulations. For example, please see the guidelines for prion experiments published elsewhere (Biosafety in Microbiological and Biomedical Laboratories 5th Edition: http://www.cdc.gov/biosafety/publications/bmbl5/BMBL.pdf).
    1. In a bio-safety cabinet, weigh a brain with an electric balance, cut it sagitally along the midline and place each hemisphere containing brain stem and cerebellum in 2 ml screw-capped micro centrifuge tube containing zirconia balls (around 800 mg), as shown in Figure 3.


      Figure 3. Dissection of prion-infected brain tissue and loading into a screw-capped micro centrifuge tube containing zirconia balls

    2. Add 1 ml of sterile D-PBS at 4 °C and homogenize it by Multi beads shocker at 3,000 rpm for 1 min at 25 °C. Repeat this homogenization process once more.
    3. Place brain homogenate into 15 ml conical tube and add appropriate volume of sterile D-PBS at 4 °C to adjust at 10% weight per volume.
    4. Aliquot them (250 μl) in 1.5 ml screw-cap micro centrifuge tubes and stored at -80 °C until use. After thawing at 25 °C, sonicate the content for 30 sec using a sealed sonicator before use.

  3. Preparation of NSC cultures
    1. Centrifuge neurosphere suspensions (ca.100-150 μm diameter) isolated from transgenic mice overexpressing murine prion protein (tga20 mice) at 200 x g for 5 min at room temperature (Iwamaru et al., 2013; Iwamaru et al., 2014). Discard the supernatant, resuspend in 2 ml of Accutase, and incubate at 37 °C for 10 min.
    2. Gently pipet up and down using ART 1000 Reach tip to dissociate neurospheres into single cells. Add 12 ml of HBSS and count the cell density of cell suspension (10 μl) by using C-Chip disposable hemocytometer. Centrifuge at 200 x g for 5 min at 25 °C and discard the supernatant. Resuspend the pellet at the concentration of 100,000 cells/ml in the Neurosphere basal medium. Dispense 2 ml of the cell suspension into a well of 6 well plates containing a glass coverslip which is prepared in step A4.
    3. Add 1 ml of Neurosphere basal medium to the cultures after two days of incubation at 37 °C in CO2 incubator.
    4. Incubate for additional one to two days until the cultures reach at 90% of confluency.


      Figure 4. Differential interference contrast micrograph of undifferentiated neural stem cell culture at 90% of confluency. (Scale bar = 100 μm)

    5. Wash the cultures with 2 ml of HBSS at 25 °C, gently hold the edge of the glass coverslips with fine forceps and transfer them into new 6 well plates which contain 2 ml of Neurosphere basal medium without bFGF (differentiation-inducing medium) per well.
    6. Change 2 ml of the differentiation-inducing medium every 2 days.
    7. After 6 days of differentiation, replace the culture medium with prion-infected brain homogenate diluted at 1:1,000 in 2 ml of the differentiation-inducing medium.
    8. After two days of infection, replace 2 ml of the culture medium with freshly prepared prion-infected brain homogenate at the same dilution, and continue to incubate for another two days.
    9. Change the differentiation-inducing medium every 2 days, until biochemical and infectivity assays of prion are performed.

Recipes

  1. Epidermal growth factor human (EGF)
    Dissolved at 50 μg /ml in sterile DMEM/F12 Ham containing 1% BSA
    Aliquoted (100 μl) and stored at -20 °C
    Use within 6 months
  2. Fibroblast growth factor-basic human (bFGF)
    Dissolved at 50 μg /ml in sterile DMEM/F12 Ham containing 1% BSA
    Aliquoted (50 μl) and stored at -20 °C
    Use within 6 months
  3. Neurosphere basal medium
    Reagents
    Volume
    Final conc.
    DMEM/F12 Ham
    487.33 ml

    EGF
    500 μl
    50 ng/ml
    bFGF
    500 μl
    50 ng/ml
    BSA
    1.67 ml
    0.1%
    N2 supplement
    5 ml
    1%
    Penicillin-streptomycin
    5 ml
    100 IU/ml and 100 μg/ml, respectively
  4. Fibronectin
    Dissolve 1 mg of fibronectin in 1 ml of sterile water for a stock solution
    Dilute the stock with water (Final concentration is 10 ug/ml) before use
  5. Glass wash solution
    Reagents
    Volume
    Final conc.
    EtOH (99.5%)
    24 ml
    74.6%
    HCl (12.1 mol/l)
    8 ml
    3.0 mol/l
  6. Differentiation-inducing medium
    Reagents
    Volume
    Final conc.
    DMEM/F12 Ham
    487.83 ml

    EGF
    500 μl
    50 ng/ml
    BSA
    1.67 ml
    0.1%
    N2 supplement
    5 ml
    1%
    Penicillin-streptomycin
    5 ml
    100 IU/ml and 100 μg/ml, respectively

Acknowledgments

This protocol was adapted from our previously published paper: Iwamaru et al. (2013). This work was supported by a Grant-in-Aid from the BSE and Other Prion Disease Control Project of the Ministry of Agriculture, Forestry, and Fisheries of Japan and by a Grant-in-Aid for Young Scientists (category B) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.

References

  1. Iwamaru, Y., Takenouchi, T., Imamura, M., Shimizu, Y., Miyazawa, K., Mohri, S., Yokoyama, T. and Kitani, H. (2013). Prion replication elicits cytopathic changes in differentiated neurosphere cultures. J Virol 87(15): 8745-8755.
  2. Iwamaru, Y., Takenouchi, and Kitani, H. (2014). Isolation and culture of neurospheres for the study of pathogenesis of prion disease. Bio-Protocol 3(6): e1081.


How to cite this protocol: Iwamaru, Y., Takenouchi, T. and Kitani, H. (2014). Neural Stem Cell Differentiation and Prion Infection. Bio-protocol 4(6): e1082. DOI: 10.21769/BioProtoc.1082; Full Text



Share Your Feedback:

  • Add Photo
  • Add Video

Bio-protocol's major goal is to make reproducing an experiment an easier task. If you have used this protocol, it would be great if you could share your experience by leaving some comments, uploading images or even sharing some videos. Please login to post your feedback.

Q&A and Troubleshooting:

  • Add Photo
  • Add Video

Please login to post your questions/comments. Your questions will be directed to the authors of the protocol. The authors will be requested to answer your questions at their earliest convenience. Once your questions are answered, you will be informed using the email address that you register with bio-protocol.
You are highly recommended to post your data (images or even videos) for the troubleshooting. For uploading videos, you may need a Google account because Bio-protocol uses YouTube to host videos.


Login | Register
Share
Twitter Twitter
LinkedIn LinkedIn
Google+ Google+
Facebook Facebook